NO157177C - Analogifremgangsmaate til fremstilling av farmakologisk virksomme muramylpeptider. - Google Patents

Analogifremgangsmaate til fremstilling av farmakologisk virksomme muramylpeptider.

Info

Publication number
NO157177C
NO157177C NO802200A NO802200A NO157177C NO 157177 C NO157177 C NO 157177C NO 802200 A NO802200 A NO 802200A NO 802200 A NO802200 A NO 802200A NO 157177 C NO157177 C NO 157177C
Authority
NO
Norway
Prior art keywords
preparation
pharmacologically effective
muramyl peptides
analogy procedure
analogy
Prior art date
Application number
NO802200A
Other languages
English (en)
Norwegian (no)
Other versions
NO802200L (no
NO157177B (no
Inventor
Lajos Tarcsay
Albert Hartmann
Gerhard Baschang
Jaroslav Stanek
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO802200L publication Critical patent/NO802200L/no
Publication of NO157177B publication Critical patent/NO157177B/no
Publication of NO157177C publication Critical patent/NO157177C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO802200A 1979-07-25 1980-07-22 Analogifremgangsmaate til fremstilling av farmakologisk virksomme muramylpeptider. NO157177C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH689379 1979-07-25
AU66581/81A AU6658181A (en) 1979-07-25 1981-01-23 Increasing antibiotic action of antibiotics

Publications (3)

Publication Number Publication Date
NO802200L NO802200L (no) 1981-01-26
NO157177B NO157177B (no) 1987-10-26
NO157177C true NO157177C (no) 1988-02-03

Family

ID=34862371

Family Applications (1)

Application Number Title Priority Date Filing Date
NO802200A NO157177C (no) 1979-07-25 1980-07-22 Analogifremgangsmaate til fremstilling av farmakologisk virksomme muramylpeptider.

Country Status (27)

Country Link
US (2) US4414204A (hu)
EP (1) EP0025495B1 (hu)
JP (1) JPS5649397A (hu)
KR (1) KR840001617B1 (hu)
AU (2) AU541147B2 (hu)
CA (1) CA1183129A (hu)
CS (1) CS276965B6 (hu)
CY (1) CY1381A (hu)
DD (1) DD153843A5 (hu)
DE (1) DE3068304D1 (hu)
DK (1) DK161025C (hu)
ES (1) ES493633A0 (hu)
FI (1) FI75578C (hu)
GR (1) GR69314B (hu)
HK (1) HK85787A (hu)
HU (1) HU188861B (hu)
IE (1) IE50145B1 (hu)
IL (1) IL60676A (hu)
MX (1) MX9203368A (hu)
MY (1) MY8700554A (hu)
NO (1) NO157177C (hu)
NZ (1) NZ194432A (hu)
PL (2) PL127481B1 (hu)
PT (1) PT71607A (hu)
SG (1) SG38187G (hu)
SU (2) SU1277905A3 (hu)
ZA (1) ZA804487B (hu)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (hu) * 1981-01-23 1984-09-26 Ciba Geigy Ag
US5334583A (en) * 1982-07-23 1994-08-02 Ciba-Geigy Corp. Use of sugar derivatives for the prophylaxis and treatment of virus infections
ATE23536T1 (de) * 1982-07-23 1986-11-15 Ciba Geigy Ag Neue muramylpeptide und verfahren zu ihrer herstellung.
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
US5189017A (en) * 1982-07-23 1993-02-23 Ciba-Geigy Corporation Use of sugar derivatives for the prophylaxis and treatment of virus infections
US4746651A (en) * 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
DE3572491D1 (en) * 1984-07-25 1989-09-28 Ciba Geigy Ag Phosphatidyl compounds, process for their preparation and their use
US4885285A (en) * 1984-09-13 1989-12-05 Ciba-Geigy Corporation Phosphorus compounds, processes for their manufacture, and their use
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US4916118A (en) * 1986-08-18 1990-04-10 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US4994440A (en) * 1989-02-13 1991-02-19 Creaven Patrick J Method for the treatment of renal cell carcinoma
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
US6156319A (en) * 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
AUPP059897A0 (en) * 1997-11-27 1998-01-08 Fujisawa Pharmaceutical Co., Ltd. New use of bicozamycin
US20040029842A1 (en) * 2001-12-18 2004-02-12 Gardner Wallace J. Triglyceride lowering, common cold and pneumonia prevention composition comprising tetracycline, and methods of treating or preventing diseases using same
EP1670508B1 (en) 2003-02-28 2012-10-24 Trustees Of The University Of Pennsylvania Compositions, methods and kits relating to poxvirus subunit vaccines
US20050079187A1 (en) * 2003-10-14 2005-04-14 Gardner Wallace J. Composition, kit and method for reducing plaque formation, tooth decay and incidence of caries
JP2008522951A (ja) * 2004-07-19 2008-07-03 ベイラー・カレツジ・オブ・メデイシン サイトカインシグナル伝達調節物質の調節および免疫療法のための応用
CN101501055B (zh) * 2005-06-23 2016-05-11 贝勒医学院 负性免疫调节因子的调节和免疫疗法应用
WO2008116347A1 (en) 2007-03-26 2008-10-02 General Regeneratives Limited Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
JP2011505144A (ja) * 2007-11-30 2011-02-24 ベイラー カレッジ オブ メディシン 樹状細胞ワクチン組成物およびその使用
CA3033133C (en) 2009-03-25 2021-11-09 The Board Of Regents Of The University Of Texas System Compositions for stimulation of mammalian innate immune resistance to pathogens
WO2011038002A1 (en) 2009-09-22 2011-03-31 Yale University Immunogenic epitopes as targets for universal cancer vaccines
EP2741785B1 (en) 2011-07-12 2018-09-05 Philadelphia Health and Education Corporation Novel clostridium difficile dna vaccine
RU2491922C1 (ru) * 2012-04-26 2013-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Способ повышения биоцидного и лечебного действия крема-суспензии с энрофлоксацином
RU2527330C2 (ru) * 2012-07-05 2014-08-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ повышения биоцидного и лечебного действия крема - суспензии с метронидазолом
EP2951199A4 (en) 2013-01-31 2016-07-20 Univ Jefferson Fusion proteins for the modulation of regulatory and effector T cells
WO2015116178A1 (en) 2014-01-31 2015-08-06 Thomas Jefferson University Fusion proteins for modulating regulatory and effector t cells
WO2016044839A2 (en) 2014-09-19 2016-03-24 The Board Of Regents Of The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10576147B2 (en) 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
WO2020140007A1 (en) 2018-12-28 2020-07-02 University Of Rochester Gene therapy for best1 dominant mutations
MX2023011004A (es) 2021-03-19 2024-01-08 Trained Therapeutix Discovery Inc Compuestos para regular la inmunidad entrenada y métodos para usarlos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001395A (en) * 1972-06-20 1977-01-04 Agence Nationale De Valorisation De La Recherche (Anvar) Hydrosoluble extracts of mycobacteria
NL7308450A (hu) * 1972-06-20 1973-12-27
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
FR2368282A1 (fr) * 1976-10-22 1978-05-19 Anvar Adjuvant immunologique constitue par le p-amino-phenyl de n-acetyl-muramyl-l-alanyl-d-isoglutamine
US4268505A (en) * 1978-04-13 1981-05-19 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider

Also Published As

Publication number Publication date
US4406890A (en) 1983-09-27
CA1183129A (en) 1985-02-26
FI75578B (fi) 1988-03-31
PL131613B1 (en) 1984-12-31
CS276965B6 (en) 1992-11-18
NO802200L (no) 1981-01-26
IE801533L (en) 1981-01-25
IL60676A (en) 1984-10-31
PT71607A (de) 1980-08-01
PL225870A1 (hu) 1981-05-08
PL127481B1 (en) 1983-10-31
KR840001617B1 (ko) 1984-10-11
FI75578C (fi) 1988-07-11
DE3068304D1 (en) 1984-07-26
ES8105971A1 (es) 1981-07-01
HU188861B (en) 1986-05-28
IE50145B1 (en) 1986-02-19
CY1381A (en) 1987-12-18
DD153843A5 (de) 1982-02-03
DK161025C (da) 1991-10-28
ES493633A0 (es) 1981-07-01
KR830003511A (ko) 1983-06-21
JPS6356239B2 (hu) 1988-11-07
FI802294A (fi) 1981-01-26
AU6078880A (en) 1981-01-29
SU1277906A3 (ru) 1986-12-15
US4414204A (en) 1983-11-08
CS526280A3 (en) 1992-06-17
NZ194432A (en) 1983-09-02
DK319480A (da) 1981-01-26
EP0025495A1 (de) 1981-03-25
MX9203368A (es) 1992-09-01
ZA804487B (en) 1981-07-29
AU6658181A (en) 1982-11-04
DK161025B (da) 1991-05-21
IL60676A0 (en) 1980-09-16
SU1277905A3 (ru) 1986-12-15
GR69314B (hu) 1982-05-14
JPS5649397A (en) 1981-05-02
MY8700554A (en) 1987-12-31
EP0025495B1 (de) 1984-06-20
AU541147B2 (en) 1984-12-20
HK85787A (en) 1987-11-27
NO157177B (no) 1987-10-26
SG38187G (en) 1988-01-15

Similar Documents

Publication Publication Date Title
NO157177C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme muramylpeptider.
NO149389C (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
NO157048C (no) Fremgangsmaate til fremstilling av en tablett.
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO152904C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme heksapyranoseforbindelser.
NO158752C (no) Fremgangsmaate til fremstilling av etanol.
NO820967L (no) Fremgangsmaate ved fremstilling av nye terapeutisk virksomme peptider.
NO148921C (no) Analogifremgangsmaate til fremstilling av immunpotenserende peptidderivater.
NO151088C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme silyl-glucosaminderivater
DK327280A (da) Fremgangsmaade til fremstilling af peptidderivater
NO156210C (no) Fremgangsmaate til fremstilling av monacolin k derivater.
NO153853C (no) Fremgangsmaate for fremstilling av 17beta-hydroksy-17alfa-pregn-5-en-21-karboksylsyre-gamma-laktoner.
NO156865C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO801142L (no) Fremgangsmaate til fremstilling av klordioksyd.
NO152645C (no) Fremgangsmaate for fremstilling av klordioksyd.
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.
NO791458L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO781489L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO148924C (no) Analogifremgangsmaate ved fremstilling av immunpotensierende peptider.
NO154088C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.
NO152840C (no) Fremgangsmaate for fremstilling av dibenzyletere.
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO800251L (no) Fremgangsmaate til fremstilling av beta-laktamforbindelser
NO148372C (no) Fremgangsmaate til fremstilling av bromheksin